179 409

Cited 3 times in

Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis

DC Field Value Language
dc.contributor.author김기열-
dc.contributor.author노미령-
dc.contributor.author오영주-
dc.contributor.author장향란-
dc.contributor.author정기양-
dc.contributor.author정희철-
dc.date.accessioned2022-07-08T03:20:54Z-
dc.date.available2022-07-08T03:20:54Z-
dc.date.issued2022-04-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188801-
dc.description.abstractThe underlying molecular mechanisms of cutaneous squamous cell carcinoma (cSCC) pathogenesis are largely unknown. In the present study, we aimed to evaluate the effect of coatomer protein complex subunit beta 2 (COPB2) expression on cSCC pathogenesis. Clinicopathological significance of COPB2 in cSCC was investigated by analyzing the Gene Expression Omnibus (GEO) database and through a retrospective cohort study of 95 cSCC patients. The effect of COPB2 expression on the biological behavior of cSCC cells was investigated both in vitro and in vivo. We found that COPB2 expression was significantly higher in cSCC samples than in normal skin samples. In our cohort, a considerable association was found between COPB2 expression and indicators of tumor immune microenvironment (TIME), such as histocompatibility complex class (MHC) I, and MHC II, CD4+/ CD8+ tumor-infiltrating lymphocytes. Additionally, COPB2 expression had an independent impact on worsened recurrence-free survival in our cohort. Furthermore, decreased proliferation, invasion, tumorigenic activities, and increased apoptosis were observed after COPB2 knockdown in cSCC cells. COPB2 may act as a potential oncogene and candidate modulator of the TIME in cSCC. Therefore, it can serve as a novel predictive prognostic biomarker and candidate immunotherapeutic target in cSCC patients.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherMDPI-
dc.relation.isPartOfCANCERS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleImplication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis-
dc.typeArticle-
dc.contributor.collegeCollege of Dentistry (치과대학)-
dc.contributor.departmentOthers-
dc.contributor.googleauthorTaiqin Chen-
dc.contributor.googleauthorKi-Yeol Kim-
dc.contributor.googleauthorYeongjoo Oh-
dc.contributor.googleauthorHei Cheul Jeung-
dc.contributor.googleauthorKee Yang Chung-
dc.contributor.googleauthorMi Ryung Roh-
dc.contributor.googleauthorXianglan Zhang-
dc.identifier.doi10.3390/cancers14082038-
dc.contributor.localIdA00337-
dc.contributor.localIdA01278-
dc.contributor.localIdA05152-
dc.contributor.localIdA03489-
dc.contributor.localIdA03582-
dc.contributor.localIdA03794-
dc.relation.journalcodeJ03449-
dc.identifier.eissn2072-6694-
dc.identifier.pmid35454945-
dc.subject.keywordCOPB2-
dc.subject.keywordcSCC-
dc.subject.keywordpathogenesis-
dc.subject.keywordtumor immune microenvironment-
dc.contributor.alternativeNameKim, Ki Yeol-
dc.contributor.affiliatedAuthor김기열-
dc.contributor.affiliatedAuthor노미령-
dc.contributor.affiliatedAuthor오영주-
dc.contributor.affiliatedAuthor장향란-
dc.contributor.affiliatedAuthor정기양-
dc.contributor.affiliatedAuthor정희철-
dc.citation.volume14-
dc.citation.number8-
dc.citation.startPage2038-
dc.identifier.bibliographicCitationCANCERS, Vol.14(8) : 2038, 2022-04-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Dermatology (피부과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
2. College of Dentistry (치과대학) > Others (기타) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.